Highlights
A collection of news and information related to Pradaxa (drug) published by this site and its partners.
Displaying items 1-12 of 13
» View baltimoresun.com items only
1
2
•
Next >
-
UE quiere nuevas guías para anticoagulante Pradaxa de Boehringer
ReutersLONDRES, 25 mayo (Reuters) - Médicos y pacientes deberían recibir guías más claras sobre cómo evitar los riesgos de hemorragia al usar el nuevo medicamento Pradaxa, de Boehringer Ingelheim, para prevenir accidentes cerebrovasculares, indicaron el...Tags: Drugs and Medicines, Bristol Myers Squibb Company, Xarelto (drug), Johnson & Johnson Inc.
-
EU body wants new guidance on Boehringer clot drug
ReutersLONDON, May 25 (Reuters) - Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim's new stroke prevention pill Pradaxa, European regulators said on Friday. The European Medicines Agency said...Tags: Europe, Johnson & Johnson Inc., Xarelto (drug), Cardiac Arrhythmia, Warfarin (drug)
-
UPDATE 3-US advisers reject J&J/Bayer's Xarelto for acute coronary patients
Reuters* Xarelto already approved for two other uses * FDA advisers concerned about missing data, bleeding risks * FDA to make a final decision by end of June By Anna Yukhananov SILVER SPRING, Md., May 23 (Reuters) - U.S. advisers recommended against...Tags: Heart Problems, Hospitals and Clinics, Bayer AG, Stroke, Legs
-
ACTUALIZA 1-FDA muestra opinión mixta sobre Xarelto de J&J
Reuters* Personal FDA menciona datos faltantes en estudios fármaco * Revisora clínica FDA recomienda aprobación * Asesores externos FDA votarán el miércoles sobre Xarelto * Acciones de J&J suben 0,2 pct; las de Bayer trepan 2,3 pct (Actualiza con...Tags: Bristol Myers Squibb Company, Bayer AG, Food and Drug Administration, Placebo, Xarelto (drug)
-
UPDATE 1-Missing data raise doubts on J&J drug-US FDA staff
ReutersWASHINGTON, May 21 (Reuters) - U.S. drug reviewers said missing data for Johnson & Johnson's blood thinner Xarelto raised doubts about whether the drug actually reduced the risk of new heart attacks and strokes in people with heart problems. The U.S....Tags: Heart Problems, Bayer AG, Stroke, Legs, Johnson & Johnson Inc.
-
Falta de datos genera dudas sobre Xarelto de J&J: FDA de EEUU
ReutersWASHINGTON, 21 mayo (Reuters) - Los revisores farmacológicos estadounidenses dijeron que la falta de algunos datos sobre el anticoagulante de Johnson & Johnson Xarelto generan dudas sobre si el medicamento realmente reduce el riesgo de nuevos ataques...Tags: Bristol Myers Squibb Company, Bayer AG, Food and Drug Administration, Xarelto (drug), Johnson & Johnson Inc.
-
UPDATE 2-FDA staff sends mixed message on J&J drug Xarelto
Reuters* FDA staff cite missing data on drug studies * FDA's clinical reviewer recommends approval * FDA advisers to vote on Xarelto on Wednesday * J&J shares rise 0.3 pct, Bayer up 2.6 pct By Anna Yukhananov WASHINGTON, May 21 (Reuters) - U.S. drug...Tags: Heart Problems, Bayer AG, Stroke, Johnson & Johnson Inc., Legs
-
UPDATE 3-FDA staff sends mixed message on J&J drug Xarelto
Reuters* FDA staff cites missing data on drug studies * FDA's clinical reviewer recommends approval * FDA advisers to vote on Xarelto on Wednesday * J&J shares rise 0.2 pct, Bayer up 2.3 pct By Anna Yukhananov WASHINGTON, May 21 (Reuters) - U.S. drug...Tags: Heart Problems, Bayer AG, Placebo, Johnson & Johnson Inc., Legs
-
Is the alternative to warfarin safe and effective?
Premium Health News ServiceQ. My wife's medication to treat atrial fibrillation recently was changed from warfarin to a new drug called Pradaxa. They say that the new medicine does not require regular INR tests and is just as effective. Is that so? A. Yes, it is so. Before I...Tags: Stroke, Drugstore.com Inc., Coumadin (drug), Food and Drug Administration, Cardiac Arrhythmia
-
|Story
-
Doctors reserve judgment on new blood clot drugs
ReutersORLANDO, Florida (Reuters) - Cardiologists are not ready to jump to any conclusions about a closely-watched group of new blood thinners and said serious questions about their safety still need to be addressed. Three new medicines that offer potential...Tags: Health and Medical Professionals, Hospitals and Clinics, Mayo Clinic, Stroke, Cardiac Arrhythmia
-
Bayer anti-clot drug gets cautious journal welcome
ReutersLONDON (Reuters) - An anti-clotting pill from Bayer and Johnson & Johnson offers a new way of preventing stroke although further studies will be needed to refine treatment options, according to a review in a top medical journal. Wednesday's editorial...Tags: Colleges and Universities, Johnson & Johnson Inc., Trials, Cardiac Arrhythmia, Warfarin (drug)
May 25, 2012
|Story| Reuters
May 25, 2012
|Story| Reuters
May 23, 2012
|Story| Reuters
May 21, 2012
|Story| Reuters
May 21, 2012
|Story| Reuters
May 21, 2012
|Story| Reuters
May 21, 2012
|Story| Reuters
May 21, 2012
|Story| Reuters
Jan 25, 2012
|Story| Tribune Media Services
Jan 10, 2012
|Story| Los Angeles Times
Nov 14, 2011
|Story| Reuters
Aug 10, 2011
|Story| Reuters
Original site for Pradaxa (drug) topic gallery.
